Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

By: |
June 30, 2021 11:07 AM

"By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract. According to CGU's preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis," Brazil Health Minister Marcelo Queiroga tweeted.

As a part of the study, blood samples were collected from 114 healthcare professionals and frontline workers who received Covaxin at vaccination centres in Chennai from February to May 2021.As a part of the study, blood samples were collected from 114 healthcare professionals and frontline workers who received Covaxin at vaccination centres in Chennai from February to May 2021.

The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotechs COVID-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal.

“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract. According to CGU’s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.

The Covaxin contract to Brazil landed in controversy after the South American countrys Attorney General reportedly launched a probe into the deal.

“It is noteworthy that the @govbr did not pay ANY CENT for the Covaxin vaccine. The measure does not compromise the pace of the vaccination campaign against #Covid19 in Brazil, since there is no approval from Anvisa for emergency or definitive use of the immunizing agent,” Queiroga said in another tweet. However, the Indian drug maker was not immediately available for a comment.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Rare intellectual disability in baby girls – Rett Syndrome
2Wife, brother-in-law of Gujarat Omicron patient test positive for coronavirus, samples sent for genome sequencing
3Covid-19: Could the Omicron variant cause milder illness?